Multiple dosing of a pegylated long-acting recombinant human growth hormone in adults subjects with growth hormone deficiency

被引：0
|
作者：
Rasmussen, Michael Hojby [1 ]
Hansen, Birgit Sehested [1 ]
Klose, Marianne Klose [2 ]
Hansen, Mette [3 ]
Sondergaard, Esben [4 ]
Andersen, Marianne [3 ]
Feldt-Rasmussen, Ulla [2 ]
Laursen, Torben [4 ]
Madsen, Jesper [1 ]
Christiansen, Jens S. [4 ]
机构：
[1] Novo Nordisk AS, Bagsvaerd, Denmark
[2] Natl Univ Copenhagen, Copenhagen, Denmark
[3] Odense Univ Hosp, Odense, Denmark
[4] Aarhus Univ Hosp, Aarhus, Denmark
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S337 / S337
页数：1
相关论文
共 50 条
  • [1] Multiple dosing of a pegylated long-acting recombinant human growth hormone in healthy subjects
    Jensen, Lene
    Anderson, Thomas
    Madsen, Jesper
    Rasmussen, Michael Hojby
    HORMONE RESEARCH, 2009, 72 : 371 - 371
  • [2] Subcutaneous injections of a pegylated long-acting recombinant human growth hormone (NNC126-0083) in adults subjects with growth hormone deficiency is well tolerated
    Hansen, Birgit S.
    Soendergaard, Esben
    Klose, Marianne
    Hansen, Mette
    Feldt-Rasmussen, Ulla
    Andersen, Marianne
    Rasmussen, Michael H.
    Christiansen, Jens S.
    HORMONE RESEARCH, 2009, 72 : 371 - 371
  • [3] Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency
    Du, Hanze
    Wu, Danning
    Yi, Pengfei
    Bai, Xi
    Luo, Yunyun
    Yang, Hongbo
    Chen, Shi
    Pan, Hui
    Zhu, Huijuan
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 35 (04): : 511 - 517
  • [4] SECONDARY DEVELOPMENT OF LONG-ACTING PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE
    Liu, Jiaxin
    Li, Chunmei
    Li, Shuang
    Liu, Zhihong
    Sun, Fengying
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (01) : 28 - 28
  • [5] Somatrogon Long-acting human growth hormone Treatment of human growth hormone deficiency
    Ribeiro, D.
    DRUGS OF THE FUTURE, 2021, 46 (07) : 515 - 519
  • [6] Pegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone Deficiency
    Sondergaard, Esben
    Klose, Marianne
    Hansen, Mette
    Hansen, Birgit Sehested
    Andersen, Marianne
    Feldt-Rasmussen, Ulla
    Laursen, Torben
    Rasmussen, Michael Hojby
    Christiansen, Jens Sandahl
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03): : 681 - 688
  • [7] Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies
    Luo, Xiaoping
    Hou, Ling
    Liang, Li
    Dong, Guanping
    Shen, Shuixian
    Zhao, Zhuhui
    Gong, Chun Xiu
    Li, Yuchuan
    Du, Min-lian
    Su, Zhe
    Du, Hongwei
    Yan, Chaoying
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 177 (02) : 195 - 205
  • [8] Subcutaneous injections of a pegylated long-acting recombinant human growth hormone are well-tolerated
    Bysted, Britta
    Anderson, Thomas W.
    Rasmussen, Michael Hojby
    HORMONE RESEARCH, 2008, 70 : 96 - 96
  • [9] Long-acting forms of growth hormone-releasing hormone and growth hormone: Effects in normal volunteers and adults with growth hormone deficiency
    Clemmons, David R.
    HORMONE RESEARCH, 2007, 68 : 178 - 181
  • [10] Lipoatrophy in growth hormone deficient patients treated with a long-acting pegylated growth hormone
    Touraine, Philippe A.
    D'Souza, Gwyn
    Kourides, Ione
    Abs, Roger
    Barclay, Paul
    Torres, Elena
    Ekman, Bertil
    HORMONE RESEARCH, 2009, 72 : 199 - 200
12345